Consensus Vaxcyte, Inc.

Equities

PCVX

US92243G1085

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 03:49:07 2026-03-11 pm EDT			5-day change	1st Jan Change
57.65 ^USD	-1.01%		-4.49%	+24.47%

Feb. 25	Analyst recommendations: IBM, Axon, Caterpillar, Fair Isaac, Gilead…
Feb. 24	Vaxcyte, Inc., Q4 2025 Earnings Call, Feb 24, 2026

Evolution of the Average Target: Vaxcyte, Inc.

Evolution of the Target Price: Vaxcyte, Inc.

Changes in Analyst Recommendations: Vaxcyte, Inc.

4ddf4.ZJGS9g5YhbTwZkAP-8tOFEUK6EKnOMnuMUDd-pt0ZlY.ScP6rEwbyf2GKxN-uKIoJBBfqxKRbZm_eAK_iMQhBDo31cqkWhDw_qAQNw~889ff8a204c0d2a2e94b56562ebe7aa1

Analysts' recommendations: Vaxcyte, Inc.

Feb. 25	Analyst recommendations: IBM, Axon, Caterpillar, Fair Isaac, Gilead…
25-10-16	Analyst recommendations: Las Vegas Sands, Alphabet, Applovin, Carmax, United AIrlines…
25-05-08	Analyst recommendations: AMD, Walt Disney, Applovin, Ionq, Uber...
25-04-01	Analyst recommendations: Autozone, Block, Ulta Beauty, Lululemon…
25-03-31	Needham Cuts Price Target on Vaxcyte to $90 From $140, Maintains Buy Rating	MT
24-09-10	Analyst recommendations: Apple, Oracle, Progressive, Dollar Tree...
24-09-10	Mizuho Boosts Price Target on Vaxcyte to $163 From $113, Maintains Outperform Rating	MT
24-03-12	Mizuho Adjusts Price Target on Vaxcyte to $113 From $69, Maintains Buy Rating	MT
24-02-28	Needham Raises Price Target on Vaxcyte to $95 From $73, Maintains Buy Rating	MT
23-12-07	Mizuho Initiates Vaxcyte With Buy Rating, Price Target is $69	MT
23-04-18	TD Cowen Starts Vaxcyte at Outperform	MT
23-04-18	BofA Securities Adjusts Price Target on Vaxcyte to $68 From $63, Keeps Buy Rating	MT
23-02-28	Guggenheim Adjusts Price Target on Vaxcyte to $65 From $66, Maintains Buy Rating	MT
23-01-03	Needham Adjusts Price Target on Vaxcyte to $58 From $52, Maintains Buy Rating	MT
22-12-16	SVB Securities Initiates Vaxcyte With Outperform Rating, Sets Price Target at $60	MT
22-12-15	Guggenheim Initiates Vaxcyte at Buy With $66 Price Target	MT
22-11-17	BTIG Starts Vaxcyte at Buy With $69 Price Target	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	VAXCYTE, INC.					+87.16%
	ARGENX SE					+31.06%
	WUXI APPTEC CO., LTD.					+41.4%
	INSMED INCORPORATED					+47.74%
	BIONTECH SE					+61.94%
	WUXI BIOLOGICS (CAYMAN) INC.					+23.9%
	GENMAB A/S					+24.6%
	AKESO, INC.					+51.67%
	SUMMIT THERAPEUTICS INC.					+92.22%
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.					+29.82%
	Average					+49.15%
	Weighted average by Cap.					+43.90%

See all sector consensus

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

11

Last Close Price

58.24USD

Average target price

109.00USD

Spread / Average Target

+87.16%

High Price Target

163.00USD

Spread / Highest target

+179.88%

Low Price Target

67.00USD

Spread / Lowest Target

+15.04%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Needham & Co.
Mizuho Securities
TD Cowen
BofA Securities
Guggenheim
SVB Securities LLC
BTIG

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

11

Last Close Price

58.24USD

Average target price

109.00USD

Spread / Average Target

+87.16%

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Equities
PCVX Stock
Consensus Vaxcyte, Inc.

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!

BENEFIT NOW